Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
4.250
+0.040 (0.95%)
At close: Jun 26, 2026, 4:00 PM EDT
4.240
-0.010 (-0.24%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$292,931
Profits / Employee
-$362,933
Market Cap
1.90B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Lakefront Biotherapeutics NV | 558 |
| Nuvation Bio | 307 |
| Syndax Pharmaceuticals | 298 |
| Monte Rosa Therapeutics | 187 |
| AnaptysBio | 104 |
| AtaiBeckley | 99 |
| Tyra Biosciences | 87 |
IOVA News
- 8 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Iovance Biotherapeutics files automatic mixed securities shelf - TheFly
- 18 days ago - Iovance Biotherapeutics Transcript: AGM 2026 - Transcripts
- 23 days ago - Iovance Biotherapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia - GlobeNewsWire
- 27 days ago - Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001 - GlobeNewsWire
- 5 weeks ago - Iovance Biotherapeutics to Present at Upcoming Conference - GlobeNewsWire
- 7 weeks ago - Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan - TheFly